Catalyst Wire Dossier Catalyst Wire Dossier

hGH-ViaDerm System

· Teva Neuroscience, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for hGH-ViaDerm System, covering 2013-09-02 to 2013-09-02. Get the full timeline:

Most recent: Clinical Trial Update: A Multi-Dose Study to Assess Tolerability, Safety and Pharmacology of hGH-ViaDerm™ System in Adults With GH-Deficiency [Phase 1]

See pricing